{
  "url": "https://www.law.cornell.edu/regulations/new-york/10-NYCRR-1004.16",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 1004.16 - Medical marihuana marketing and advertising by registered organizations",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 1004.16 - Medical marihuana marketing and advertising by registered organizations\n\nState Regulations\n(a) All physical\nstructures owned, leased or otherwise utilized by a registered organization, including any dispensing facility, shall: (1)\nnot advertise medical marihuana brand names or utilize graphics related to\nmarihuana or paraphernalia on the exterior of the physical structures; and\n(2)\nnot display medical\nmarihuana products and paraphernalia so as to be clearly visible from the\nexterior of a physical structure. (b) All restrictions listed in subdivision\n(a) of this section shall apply to any item located on any real property on\nwhich a registered organization's physical structures is located. (c) All restrictions listed in subdivision\n(a) of this section shall apply to all vehicles owned, leased or utilized by a\nregistered organization. (d) All\nadvertisements, regardless of form, for approved medical marihuana products\nthat make a statement relating to effectiveness, side effects, consequences or\ncontraindications shall present a true and accurate statement of such\ninformation. (e) An advertisement\ndoes not satisfy the requirement that it presents a \"true and accurate\nstatement\" of information relating to effectiveness, side effects, consequences, and contraindications if it fails to present a fair balance\nbetween information relating to effectiveness, side effects, consequences, and\ncontraindications in that the information relating to effectiveness is\npresented in greater scope, depth, or detail than is the information relating\nto side effects, consequences and contraindications, taking into account all\nimplementing factors such as typography, layout, contrast, headlines, paragraphing, white space, and any other techniques apt to achieve\nemphasis. (f) An advertisement is\nfalse, lacking in fair balance, or otherwise misleading if it: (1)\ncontains a representation or suggestion\nthat one marihuana brand or form is better, more effective, useful in a broader\nrange of conditions or patients or safer than other drugs or treatments\nincluding other marihuana brands or forms, unless such a claim has been\ndemonstrated by substantial scientific or clinical experience; (2)\ncontains favorable information or\nopinions about a marihuana product previously regarded as valid but which have\nbeen rendered invalid by contrary and more credible recent\ninformation; (3)\nuses a quote or\nparaphrase out of context or without citing conflicting information from the\nsame source, to convey a false or misleading idea; (4)\nuses a study on persons without a\ndebilitating medical condition without disclosing that the subjects were not\nsuffering from a debilitating medical condition; (5)\nuses data favorable to a marihuana\nproduct derived from patients treated with a different product or dosages\ndifferent from those recommended in New York State; (6)\ncontains favorable information or\nconclusions from a study that is inadequate in design, scope, or conduct to\nfurnish significant support for such information or conclusions; or\n(7)\nfails to provide adequate emphasis for\nthe fact that two or more facing pages are part of the same advertisement when\nonly one page contains information relating to side effects, consequences and\ncontraindications. (g) False or misleading information in any part of the advertisement shall not be\ncorrected by the inclusion of a true statement in another distinct part of the\nadvertisement. (h) An advertisement\nfor any approved medical marihuana product shall not contain: (1)\nany statement that is false or\nmisleading; (2)\nany statement that\nfalsely disparages a competitor's products; (3)\nany statement, design, or representation, picture or illustration that is obscene or indecent; (4)\nany statement, design, representation, picture or illustration that encourages or represents the use of marihuana for\na condition other than a serious condition as defined in subdivision 7 of\nsection\n3360\nof the\n\nPublic Health Law; (5)\nany\nstatement, design, representation, picture or illustration that encourages or\nrepresents the recreational use of marihuana; (6)\nany statement, design, representation, picture or illustration related to the safety or efficacy of marihuana, unless\nsupported by substantial evidence or substantial clinical data; (7)\nany statement, design, representation, picture or illustration portraying anyone under the age of 18, objects\nsuggestive of the presence of anyone under the age of 18, or containing the use\nof a figure, symbol or language that is customarily associated with anyone\nunder the age of 18; (8)\nany offer\nof a prize, award or inducement to a certified patient, designated caregiver or\npractitioner related to the purchase of marihuana or a certification for the\nuse of marihuana; or\n(9)\nany\nstatement that indicates or implies that the product or entity in the\nadvertisement has been approved or endorsed by the commissioner, department, New York State or any person or entity associated with New York State provided\nthat this shall not preclude a factual statement that an entity is a registered\norganization. (i) Any\nadvertisement for an approved medical marihuana product, which makes any claims\nor statements regarding efficacy, product shall be submitted to the department\nat least 10 business days prior to the public dissemination of the\nadvertisement. (j) The submitter of\nthe advertisement shall provide the following information to the department in\naddition to the advertisement itself: (1)\na\ncover letter that: (i) provides the following\nsubject line: Medical marihuana advertisement review package for a proposed\nadvertisement; (ii)\nprovides a\nbrief description of the format and expected distribution of the proposed\nadvertisement; and\n(iii)\nprovides\nthe submitter's name, title, address, telephone number, fax number, and email\naddress; (2)\nan\nannotated summary of the proposed advertisement showing every claim being made\nin the advertisement and which references support for each claim; (3)\nverification that a person identified in\nan advertisement as an actual patient or health care practitioner is an actual\npatient or health care practitioner and not a model or actor; (4)\nverification that a spokesperson who is\nrepresented as an actual patient is indeed an actual patient; (5)\nverification that an official translation\nof a foreign language advertisement is accurate; (6)\nannotated references to support disease\nor epidemiology information, cross-referenced to the advertisement summary; and\n(7)\na final copy of the\nadvertisement, including a video where applicable, in a format acceptable to\nthe department. (k) Advertising packages that are missing any of the elements in subdivision (j) of\nthis section, or that fail to follow the specific instructions for submissions, shall be considered incomplete. If the department receives an incomplete\npackage, it shall so notify the submitter. (l) No advertisement may be disseminated if\nthe submitter of the advertisement has received information that has not been\nwidely publicized in medical literature that the use of any approved medical\nmarihuana product may cause fatalities or serious damage to a\npatient. (m) A registered\norganization, its officers, managers and employees shall not cooperate, directly or indirectly, in any advertising if such advertising has the purpose\nor effect of steering or influencing patient or caregiver choice with regard to\nthe selection of a practitioner. Nothing contained within this section prevents\na registered organization from educating practitioners about approved medical\nmarihuana products offered by the registered organization. (n) The department may: (1)\nrequire a specific disclosure be made in\nthe advertisement in a clear and conspicuous manner if the department\ndetermines that the advertisement would be false or misleading without such a\ndisclosure; or\n(2)\nrequire that\nchanges be made to the advertisement that are: (i) necessary to protect the public health, safety and welfare; or\n(ii)\nconsistent with dispensing information for the product under review. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 10\nยง\n1004.16\n\nAdopted, New\n\nYork State Register April 15, 2015/Volume XXXVII, Issue 15, eff. 4/15/2015\n\nAmended\n\nNew\n\nYork State Register December 27, 2017 /Volume XXXIX, Issue 52, eff. 12/27/2017\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 12580
}